Ultramercial Needs Post-Prometheus Review, WildTangent Says

Law360, New York (May 7, 2012, 10:20 PM EDT) -- A Federal Circuit ruling that Ultramercial LLC's patent for viewing ads in exchange for access to online content is valid should be vacated or reversed in light of the Supreme Court's recent Prometheus ruling, defendant WildTangent Inc. said in a high court brief filed Friday.

In a response to WildTangent's Supreme Court petition filed last week, Ultramercial argued that the Prometheus case, which dealt with blood tests, did not apply to computer-related inventions. Further, it said that the validity of its patent would not open the...
To view the full article, register now.